CRVS - Company ID 0001626971
As of 2026-11-06, Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $821.86 M, making it the #2580 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $821.86 M |
| 2026-11-05 | $818.50 M |
| 2026-11-04 | $875.53 M |
| 2026-11-03 | $826.07 M |
| 2026-11-02 | $815.97 M |
| 2026-11-01 | $843.43 M |
| 2026-10-31 | $843.43 M |
| 2026-10-30 | $832.50 M |
| 2026-10-29 | $860.25 M |
| 2026-10-28 | $881.27 M |
| 2026-10-27 | $884.21 M |
| 2026-10-26 | $878.74 M |
As of 2026-11-06, Corvus Pharmaceuticals, Inc. (CRVS) has a market capitalization of $821.86 M, making it the #2580 most valuable US-listed company.
Corvus Pharmaceuticals, Inc. is the #2580 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $885.47 M |
| 2026-10-24 | $885.47 M |
| 2026-10-23 | $885.47 M |
| 2026-10-22 | $873.70 M |
| 2026-10-21 | $845.11 M |
| 2026-10-20 | $860.25 M |
| 2026-10-19 | $811.47 M |
| 2026-10-18 | $800.54 M |
| 2026-10-17 | $800.54 M |
| 2026-10-16 | $800.54 M |
| 2026-10-15 | $828.29 M |
| 2026-10-14 | $788.77 M |
| 2026-10-13 | $791.29 M |
| 2026-10-12 | $845.11 M |
| 2026-10-11 | $884.63 M |
| 2026-10-10 | $884.63 M |
| 2026-10-09 | $884.63 M |
| 2026-10-08 | $858.56 M |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.